- Home
- DTIL vs CFBK Comparison
DTIL vs CFBK Comparison
Compare DTIL & CFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DTIL | CFBK |
|---|---|---|
| Founded | 2006 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.3M | 182.3M |
| IPO Year | 2019 | 2005 |
Fundamental Metrics
Financial Performance| Metric | DTIL | CFBK |
|---|---|---|
| Price | $7.01 | $29.53 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $45.00 | $31.50 |
| AVG Volume (30 Days) | ★ 232.9K | 27.0K |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 1.22% |
| EPS Growth | N/A | ★ 30.58 |
| EPS | N/A | ★ 2.69 |
| Revenue | ★ $1,070,000,000.00 | N/A |
| Revenue This Year | N/A | $31.99 |
| Revenue Next Year | N/A | $9.09 |
| P/E Ratio | ★ N/A | $10.98 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.53 | $22.10 |
| 52 Week High | $8.82 | $34.34 |
Technical Indicators
Market Signals| Indicator | DTIL | CFBK |
|---|---|---|
| Relative Strength Index (RSI) | 55.65 | 55.27 |
| Support Level | $4.56 | $28.40 |
| Resistance Level | $7.84 | $30.23 |
| Average True Range (ATR) | 0.53 | 0.64 |
| MACD | -0.02 | 0.09 |
| Stochastic Oscillator | 59.50 | 51.46 |
Price Performance
Historical ComparisonAbout DTIL Precision BioSciences Inc.
Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).
About CFBK CF Bankshares Inc.
CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans, and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.